Literature DB >> 535248

Tibial tubercle transfer: a long-range follow-up study.

J W Fielding, W A Liebler, N D Krishne Urs, S A Wilson, A S Puglisi.   

Abstract

The prime indications for tibial tubercle transfer are 2 or more complete patellar dislocations with trivial trauma or recurrent subluxation with or without pain causing "giving way." A high "Q" angle, flat lateral condyle, aplastic patella or positive apprehension test may be associated but are not always prime indications in surgery. Methods of fixation are of individual preference in this series and a single screw sufficed. An arthrotomy is not always necessary but is suggested if indicated. If the proximal tibial epiphysis is open, corrective measures are suggested that do not involve the extension of the proximal tibial epiphysis into the tibial tubercle. The tubercle should be advanced to compensate for patella alta and lined up with the femoral shaft. Transplantation of the tubercle medially 3/4'' and distally 1/2'' was generally satisfactory in a series of 377 operations with an average follow up of 3 1/2 years.

Entities:  

Mesh:

Year:  1979        PMID: 535248

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  Results in the treatment of recurrent dislocation of the patella after 30 years' follow-up.

Authors:  M Marcacci; S Zaffagnini; F Iacono; A Visani; A Petitto; N P Neri
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1995       Impact factor: 4.342

2.  Dynamic knee brace in the treatment of patellofemoral disorders.

Authors:  B N Møller; B Krebs
Journal:  Arch Orthop Trauma Surg       Date:  1986

3.  Vastus medialis advancement: clinical results and correlation with tangential X-rays of the patellofemoral joint.

Authors:  J O'Beirne; R J O'Connell; M White
Journal:  Ir J Med Sci       Date:  1986-10       Impact factor: 1.568

4.  A 10 year follow-up study after Roux-Elmslie-Trillat treatment for cases of patellar instability.

Authors:  Stefan Endres; Axel Wilke
Journal:  BMC Musculoskelet Disord       Date:  2011-02-18       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.